Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome
申请人:Abbott Laboratories
公开号:US07928243B2
公开(公告)日:2011-04-19
The present invention relates to compounds of formula (I):
Pharmaceutical compositions and methods that are useful in the treatment or prevention of metabolic diseases or conditions are also provided.